144 related articles for article (PubMed ID: 7796671)
21. Detection of capsid antigen of human papillomavirus (HPV) in benign lesions of female genital tract using anti-HPV monoclonal antibody.
Iwasaki T; Sata T; Sugase M; Sato Y; Kurata T; Suzuki K; Ohmoto H; Iwamoto S; Matsukura T
J Pathol; 1992 Nov; 168(3):293-300. PubMed ID: 1335045
[TBL] [Abstract][Full Text] [Related]
22. Epidermotropism of T cells correlates with intercellular adhesion molecule (ICAM1) expression in human papillomavirus (HPV)-induced lesions.
Viac J; Chardonnet Y; Euvrard S; Schmitt D
J Pathol; 1992 Nov; 168(3):301-6. PubMed ID: 1361527
[TBL] [Abstract][Full Text] [Related]
23. Delayed-type hypersensitivity response to human papillomavirus type 16 E6 protein in a mouse model.
Chambers MA; Stacey SN; Arrand JR; Stanley MA
J Gen Virol; 1994 Jan; 75 ( Pt 1)():165-9. PubMed ID: 7906707
[TBL] [Abstract][Full Text] [Related]
24. Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization.
Daemen T; Riezebos-Brilman A; Regts J; Dontje B; van der Zee A; Wilschut J
Antivir Ther; 2004 Oct; 9(5):733-42. PubMed ID: 15535411
[TBL] [Abstract][Full Text] [Related]
25. Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7.
Daemen T; Regts J; Holtrop M; Wilschut J
Gene Ther; 2002 Jan; 9(2):85-94. PubMed ID: 11857066
[TBL] [Abstract][Full Text] [Related]
26. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
27. Viral recombinant vaccines to the E6 and E7 antigens of HPV-16.
He Z; Wlazlo AP; Kowalczyk DW; Cheng J; Xiang ZQ; Giles-Davis W; Ertl HC
Virology; 2000 Apr; 270(1):146-61. PubMed ID: 10772987
[TBL] [Abstract][Full Text] [Related]
28. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
29. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
30. Cytokine profile of draining lymph node lymphocytes in mice grafted with syngeneic keratinocytes expressing human papillomavirus type 16 E7 protein.
López MC; Stanley MA
J Gen Virol; 2000 May; 81(Pt 5):1175-82. PubMed ID: 10769058
[TBL] [Abstract][Full Text] [Related]
31. Post-transcriptional induction of p21cip1 protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes.
Jian Y; Schmidt-Grimminger DC; Chien WM; Wu X; Broker TR; Chow LT
Oncogene; 1998 Oct; 17(16):2027-38. PubMed ID: 9798674
[TBL] [Abstract][Full Text] [Related]
32. Interaction of human papillomaviruses with the host immune system: a well evolved relationship.
Frazer IH
Virology; 2009 Feb; 384(2):410-4. PubMed ID: 18986661
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model.
Vambutas A; DeVoti J; Nouri M; Drijfhout JW; Lipford GB; Bonagura VR; van der Burg SH; Melief CJ
Vaccine; 2005 Nov; 23(45):5271-80. PubMed ID: 16054734
[TBL] [Abstract][Full Text] [Related]
34. [Immunity of the female genital tract mucosa and mechanisms of papillomavirus evasion].
Riethmuller D; Seilles E
J Gynecol Obstet Biol Reprod (Paris); 2000 Dec; 29(8):729-740. PubMed ID: 11139708
[TBL] [Abstract][Full Text] [Related]
35. Expression of immune associated surface antigens of keratinocytes in human papillomavirus-derived lesions.
Viac J; Soler C; Chardonnet Y; Euvrard S; Schmitt D
Immunobiology; 1993 Aug; 188(4-5):392-402. PubMed ID: 7503944
[TBL] [Abstract][Full Text] [Related]
36. [Papilloma viruses: group-specific antigens within lesions of the oral mucosa].
Gogusev J; Lesec G; Gogusev P; Mondie JY; Peyrot J; Jourde J
Rev Stomatol Chir Maxillofac; 1986; 87(1):14-24. PubMed ID: 2421394
[TBL] [Abstract][Full Text] [Related]
37. Identification of human papillomavirus seroconversions.
Wikström A; van Doornum GJ; Quint WG; Schiller JT; Dillner J
J Gen Virol; 1995 Mar; 76 ( Pt 3)():529-39. PubMed ID: 7897345
[TBL] [Abstract][Full Text] [Related]
38. Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model.
McLean CS; Sterling JS; Mowat J; Nash AA; Stanley MA
J Gen Virol; 1993 Feb; 74 ( Pt 2)():239-45. PubMed ID: 8381463
[TBL] [Abstract][Full Text] [Related]
39. Humoral immune response to human papillomavirus infection.
Carter JJ; Galloway DA
Clin Dermatol; 1997; 15(2):249-59. PubMed ID: 9167909
[No Abstract] [Full Text] [Related]
40. Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7.
Höpfl R; Heim K; Christensen N; Zumbach K; Wieland U; Volgger B; Widschwendter A; Haimbuchner S; Müller-Holzner E; Pawlita M; Pfister H; Fritsch P
Lancet; 2000 Dec; 356(9246):1985-6. PubMed ID: 11130532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
